Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1995-08-17
1997-07-29
Elliott, George G.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 253, C07H 2104, A61K 4800
Patent
active
056523564
ABSTRACT:
The invention relates to modified oligonucleotides that are useful for studies of gene expression and for the antisense therapeutic approach. The invention provides inverted hybrid oligonucleotides and inverted chimeric oligonucleotides, both of which produce reduced side effects, relative to traditional phosphorothioate, hybrid or chimeric oligonucleotides.
REFERENCES:
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 5149797 (1992-09-01), Pederson et al.
patent: 5194428 (1993-03-01), Agrawal et al.
Monia et al. (1993) The Journal of Biological Chemistry 268:14514-14522.
Paterson et al., "Proc. Natl. Acad. Sci. USA 74", 4370-4374 (1977).
Zamecnik and Stephenson, "Proc. Natl. Acad. Sci. USA 75", 280-284 (1978).
Stephenson and Zamecnik, "Proc. Natl. Acad. Sci. USA 75", 285-288 (1978).
Agrawal, "Trends in Biotechnology 10", 152-158 (1992).
Tao et al., "Antisense Research and Development 5", 123-129 (1995).
Agrawal and Iyer, "Current Opinion in Biotechnology 6", 12-19 (1995).
Agrawal et al., "Clinical Pharmacokinetics 28", 7-16 (1995).
Zhang et al., "Clinical Pharmacology and Therapeutics 58", 44-53 (1995).
Krieg et al., "Nature 374", 546-549 (1995).
Galbraith et al., "Antisense Research and Development 4", 201-206 (1994).
Iyer et al., "Tetrahedron Asymmetry 6", 1051-1054 (1995).
Kandimalla et al., "Nucleosides and Nucleotides 14", 1031-1035 (1995).
Beaucage, "In Protocols for Oligonucleotides and Analogs: Synthesis and Properties", Agrawal (editor), pp. 33-62, Humana Press, Totowa, NJ (1993).
Agrawal & Goodchild, "Tet. Lett. 28", 3539-3542 (1987).
Kabat and Mayer (eds), "Experimental Immunochemistry, 2d Edition", 135-240, Springfield, IL, CC Thomas (1961).
Elliott George G.
Houtteman Scott W.
Hybridon, Inc.
LandOfFree
Inverted chimeric and hybrid oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inverted chimeric and hybrid oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inverted chimeric and hybrid oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-634763